Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 256

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 256
---
Gilles Schnepp (independent director)Antoine Yver(b) |
|                    | Proportion of independent directors: 60% (3/5)                                                      | Proportion of independent directors: 66% (4/6)                                                                     |

(a) Jean-Paul Kress was appointed as member of the Strategy Committee by a Board decision of December 19, 2024, with effect from January 1, 2025, to replace Gilles Schnepp who left office on December 31, 2024. (b) Antoine Yver was appointed as a member of the Strategy Committee by a Board decision of April 30, 2024.

| SANOFIFORM 20-F2024 | 153 |

| PART I                                             |
| ITEM 6. Directors, Senior Management and Employees |

Work of the Committee in 2024 During 2024, the Committee's work included the following key issues:

| l | Divestment and acquisition projects, and business development priorities. |
| l | Update on phase 2 of the Play to Win strategy.                            |
| « | Update on the Opella separation, including options review.                |
| « | Review of the Opella business plan.                                       |
| « | Update on investments in Manufacturing & Supply projects.                 |
| « | Update on the transformation plan for France.                             |

| lAnnual items | «Non-recurring items |

Attendance rates in 2024 The Committee met five times in 2024, with an overall attendance rate of 93%. Scientific Committee Composition of the Committee in 2024

| Scientific Committee | Composition as of January 1, 2024                                                                          | Composition as of December 31, 2024(a)                                                                   |
|:---------------------|:-----------------------------------------------------------------------------------------------------------|:---------------------------------------------------------------------------------------------------------|
| Chair                | Thomas Südhof (independent director)                                                                       | Antoine Yver (independent director)                                                                      |
| Members              | Frédéric Oudéa (independent director)Emile Voest (independent director)Antoine Yver (independent director) | Frédéric Oudéa (independent director)John Sundy (independent director)Emile Voest (independent director) |
|                      | Proportion of independent directors: 100% (4/4)                                                            | Proportion of independent directors: 100% (4/4)                                                          |

(a) Jean-Paul Kress was appointed as a member of the Scientific Committee by a